Interstitial lung diseases
Pulmonary vascular diseases
Respiratory critical care
Oral presentation
Respiratory function after COVID-19 and mechanical ventilation
COVID
Aims : This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
Methods :
Epidemiology, General respiratory patient care, Pulmonary function testing, Pulmonary rehabilitation, Physiology
16:30
Introduction
1
OA4043
16:35
Pulmonary function after COVID-19 infection and the impact of disease severity.
M. Thomas(Birmingham, United Kingdom)
COI
2
16:40
Neural respiratory drive in survivors of severe COVID-19 pneumonitis
C. Jolley(London, United Kingdom)
COI
3
16:45
The role of 6MWT in Covid-19 follow up
M. Ferioli(Sermide (MN), Italy)
COI
4
16:50
Half of COVID-19 ICU-treated patients have impaired lung function four months after discharge
E. Ekbom(Uppsala, Sweden)
COI
5
16:55
The impact of COVID-19 on children with chronic suppurative lung disease
T. Tolufase(Lincoln, United Kingdom)
COI
6
17:00
Pulmonary function 45 and 180 days after COVID-19 hospitalization: does time, in fact, heal all wounds?
E. Viana Mancuzo(Belo Horizonte (MG), Brazil)
COI
7
17:05
Which severe COVID-19 patients may benefit the most from pulmonary rehabilitation?
M. Marillier(Echirolles, France)
COI
8
17:10
Association between symptoms and objective physiological outcomes in severe COVID-19 pneumonia survivors
C. Jolley(London, United Kingdom)
COI
9
17:15
Diaphragm neurostimulation on every breath preserves alveolar homogeneity.
E. Rohrs(Surrey, Canada)
COI
10
17:20
Late Breaking Abstract - Lung function before and after COVID-19 infection in young adults
I. Mogensen(Skarpnäck, Stockholm, Sweden)
COI
11
17:25
Discussion
12
OA4054
. . .
